ReP USP - Resultado da busca

Artigo de periodico
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy (2022)
Lima, Keli Cristina de ; Martins, Diego Antonio Pereira ; Miranda, Lívia Bassani Lins De ; Silva, Juan Luiz Coelho ; Leandro, Giovana da Silva ; Weinhäuser, Isabel ; Cavaglieri, Rita de Cássia; Leal, Aline de Medeiros; Silva, Wellington Fernandes da; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Rego, Eduardo Magalhães ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Ammatuna, Emanuele ; Huls, Gerwin ; Schuringa, Jan Jacob ; Machado Neto, João Agostinho
Source: Blood Cancer Journal. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HOMEOSTASE, APOPTOSE, MITOCÔNDRIAS, ESPECTROMETRIA DE MASSAS, CROMATOGRAFIA LÍQUIDA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41408-022-00747-w. Acesso em: 12 jun. 2024.
APA
Lima, K. C. de, Martins, D. A. P., Miranda, L. B. L. D., Silva, J. L. C., Leandro, G. da S., Weinhäuser, I., et al. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12, 1-11. doi:10.1038/s41408-022-00747-w
NLM
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Vancouver
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Artigo de periodico
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells (2022)
Miranda, Lívia Bassani Lins De ; Lima, Keli Cristina de ; Silva, Juan Luiz Coelho ; Traina, Fabiola ; Kobayashi, Susumu S. ; Machado Neto, João Agostinho
Source: Scientific Reports. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES, TRANSDUÇÃO DE SINAL CELULAR, PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Lívia Bassani Lins De et al. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-21419-6. Acesso em: 12 jun. 2024.
APA
Miranda, L. B. L. D., Lima, K. C. de, Silva, J. L. C., Traina, F., Kobayashi, S. S., & Machado Neto, J. A. (2022). NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, 12, 1-11. doi:10.1038/s41598-022-21419-6
NLM
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Vancouver
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Artigo de periodico
Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells (2022)
Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto ; Silva, Juan Luiz Coelho ; Scheucher, Priscila Santos ; Rego, Eduardo Magalhães ; Pontes, Lorena Lôbo Figueiredo ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Toxicology in Vitro. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, INIBIDORES QUÍMICOS, MEDULA ÓSSEA, CÉLULAS-TRONCO, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO, CÉLULAS MIELOIDES, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Jaqueline Cristina et al. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, v. 83, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2022.105384. Acesso em: 12 jun. 2024.
APA
Fernandes, J. C., Fenerich, B. A., Silva, A. B. A., Fonseca, N. P., Silva, J. L. C., Scheucher, P. S., et al. (2022). Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, 83, 1-7. doi:10.1016/j.tiv.2022.105384
NLM
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Vancouver
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Artigo de periodico
Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms (2022)
Takei, Hisashi; Silva, Juan Luiz Coelho ; Leal, Cristina Tavares; Rocha, Adriana Queiroz Arantes; Bianco, Thiago Mantello ; Welner, Robert S.; Mishima, Yuta ; Kobayashi, Ikei S.; Mullally, Ann ; Lima, Keli Cristina de ; Machado Neto, João Agostinho ; Kobayashi, Susumu S. ; Pontes, Lorena Lobo De Figueiredo
Source: Cancer Science. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, PROTEÍNAS PROTO-ONCOGÊNICAS, INIBIDORES DE ENZIMAS, MODELOS ANIMAIS DE DOENÇAS, FÁRMACOS, MEDICAMENTO, NEOPLASIAS, PROLIFERAÇÃO CELULAR, SOBREVIVÊNCIA CELULAR, CAMUNDONGOS, MUTAÇÃO, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKEI, Hisashi et al. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, v. 113, n. 2, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.1111/cas.15210. Acesso em: 12 jun. 2024.
APA
Takei, H., Silva, J. L. C., Leal, C. T., Rocha, A. Q. A., Bianco, T. M., Welner, R. S., et al. (2022). Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms. Cancer Science, 113( 2), 1-12. doi:10.1111/cas.15210
NLM
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1111/cas.15210
Vancouver
Takei H, Silva JLC, Leal CT, Rocha AQA, Bianco TM, Welner RS, Mishima Y, Kobayashi IS, Mullally A, Lima KC de, Machado Neto JA, Kobayashi SS, Pontes LLDF. Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms [Internet]. Cancer Science. 2022 ; 113( 2): 1-12.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1111/cas.15210
Artigo de periodico
Molecular-based score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome (2021)
Silva, Juan Luiz Coelho ; Silveira, Douglas Rafaele Almeida ; Martins, Diego Antonio Pereira ; Rojas, Cesar A. O.; Araujo, Antonio R. Lucena ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho ; Bendit, Israel ; Rocha, Vanderson Geraldo ; Traina, Fabiola
Source: Scientific Reports. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, FARMACOGENÉTICA, EXPRESSÃO GÊNICA, CICLO CELULAR, MEDULA ÓSSEA, DOENÇAS SANGUÍNEAS E LINFÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juan Luiz Coelho et al. Molecular-based score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome. Scientific Reports, v. 11, p. 11 , 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-80918-6. Acesso em: 12 jun. 2024.
APA
Silva, J. L. C., Silveira, D. R. A., Martins, D. A. P., Rojas, C. A. O., Araujo, A. R. L., Rego, E. M., et al. (2021). Molecular-based score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome. Scientific Reports, 11, 11 . doi:10.1038/s41598-020-80918-6
NLM
Silva JLC, Silveira DRA, Martins DAP, Rojas CAO, Araujo ARL, Rego EM, Machado Neto JA, Bendit I, Rocha VG, Traina F. Molecular-based score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome [Internet]. Scientific Reports. 2021 ; 11 11 .[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41598-020-80918-6
Vancouver
Silva JLC, Silveira DRA, Martins DAP, Rojas CAO, Araujo ARL, Rego EM, Machado Neto JA, Bendit I, Rocha VG, Traina F. Molecular-based score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome [Internet]. Scientific Reports. 2021 ; 11 11 .[citado 2024 jun. 12 ] Available from: https://doi.org/10.1038/s41598-020-80918-6

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation